Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

Why a twice‑yearly injection might prove to be a good shot Lenacapavir is a first-in-class HIV drug that works by targeting ...

近日，美国食品药品监督管理局（FDA）正式批准了由吉利德（Gilead）公司研发的全新艾滋病病毒（HIV）预防药物——来那卡帕韦（Lenacapavir）。这款 ...

编者按：美国食品药品管理局（FDA）于当地时间6月18日批准了吉利德科学公司（Gilead Sciences, Inc.）的注射用HIV-1衣壳抑制剂Yeztugo（来那帕韦 ...

红枫湾APP： firstwordpharma.com消息，默沙东 (也译为默克）的一款长效（ 每月1次 ） 口服 HIV预防药物也宣布进入后期（III期）试验阶段，即将为HIV PrEP（暴露前预防）再添新选择。

Rwanda is among the countries interested in Lenacapavir, a newly approved, long-acting preventive injection, though its cost is seemingly out of reach for many developing countries. Manufactured by US ...

距离lenacapavir用于HIV预防在美国获批仅8个工作日，这一国际领先的创新药物就在博鳌乐城实现了“全球同步”准入，以“零时差”完成从海外获批到 ...

The introduction of a revolutionary drug, Lenacapavir, is poised to alter the landscape of healthcare across sub-Saharan ...

Although Uganda participated in a groundbreaking trial for Lenacapavir—an injectable drug proven effective in preventing ...

Unfortunately, the Trump administration and the Republican majorities in Congress are putting access to lifesaving ...